Find Your Funding Opportunity
Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
03-10-2025 | $2.3 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 3
- Opportunity Type Discretionary
-
CFDA
93.084 -- Prevention of Disease, Disability, and Death by Infectious Diseases
Description
The purpose of this NOFO is to improve awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding.The NOFO strategies are to:(1) TRACK – Conduct public health surveillance for AGS. This strategy could involve patient populations or geographic locations with limited access to specialized healthcare provider care. Health equity impacts should be considered.(2) EDUCATE – Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, etc.). Communications targeted at healthcare providers, healthcare provider educational resources, and training would also fall under this strategy.(3) SHARE – Disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Additional Eligibility Information
NA
Key Date(s)
- August 06, 2024: Forecasted Date
- October 15, 2024: Last Updated Date
- January 07, 2025: Estimated Post Date
- March 10, 2025: Estimated Application Due Date
- April 09, 2025: Application Archive Date
- July 01, 2025: Estimated Project Start Date
- July 01, 2025: Estimated Award Date